Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
StAR-related lipid transfer protein 6 (STARD6) is a member of the START (StAR-related lipid transfer) domain-containing protein family, which are evolutionarily conserved proteins involved in the non-vesicular, intracellular transport of lipids, such as sterols (including cholesterol and steroid hormones)[3][4]. STARD6 adopts an α/β helix-grip fold structure and specifically binds C19 and C21 steroids, including testosterone[1][3]. It is primarily expressed in testicular germ cells, suggesting a specialized role in spermatogenesis and germ cell maturation[2]. While implicated as a transport and binding protein for critical lipids and steroids in cells, its detailed physiological functions and endogenous ligands are still an active area of research, and there are no known drugs that directly modulate its activity[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on StAR-related lipid transfer protein 6 (STARD6).